Provided by Tiger Trade Technology Pte. Ltd.

Evolus Inc.

6.09
-0.3600-5.58%
Post-market: 6.090.00000.00%18:25 EDT
Volume:627.50K
Turnover:3.91M
Market Cap:401.06M
PE:-9.09
High:6.50
Open:6.50
Low:6.08
Close:6.45
52wk High:10.62
52wk Low:3.86
Shares:65.85M
Float Shares:50.04M
Volume Ratio:0.89
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6697
EPS(LYR):-0.8010
ROE:-18729.61%
ROA:-9.06%
PB:-13.93
PE(LYR):-7.60

Loading ...

Evolus management joins Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 19

3 High-Growth Insider-Owned Companies With Earnings Surging Up To 80%

Simply Wall St.
·
May 15

Evolus Plans to Launch Estyme Collection in Europe

MT Newswires Live
·
May 11

Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

THOMSON REUTERS
·
May 11

Evolus Faces Heightened Operational Risk from Overseas Manufacturing and Disaster Recovery Gaps

TIPRANKS
·
May 06

BTIG Sticks to Their Buy Rating for Evolus (EOLS)

TIPRANKS
·
May 05

Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB)

TIPRANKS
·
May 05

Evolus Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Evolus publishes investor presentation outlining aesthetics growth strategy and Evolysse rollout

Reuters
·
May 05

Evolus publishes scientific investor presentation on Evolysse hyaluronic acid filler technology

Reuters
·
May 05

Evolus Q1 revenue rises 7% on product sales

Reuters
·
May 05

Evolus Q1 operating loss narrows to $6.8 million; revenue rises 7% to $73.1 million

Reuters
·
May 05

Evolus Q1 Adj. EPS $(0.16) Misses $(0.13) Estimate, Sales $73.137M Beat $72.288M Estimate

Benzinga
·
May 05

BRIEF-Evolus Q1 Product Revenue USD 72.747 Million

Reuters
·
May 05

Evolus Q1 Gross Profit USD 48.897 Million

THOMSON REUTERS
·
May 05

Evolus Inc - Reaffirms FY 2026 Net Revenue Guidance

THOMSON REUTERS
·
May 05

Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted Ebitda and Reaffirms Full-Year Outlook

THOMSON REUTERS
·
May 05

Evolus Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
May 02

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Evolus (EOLS) and Bausch Health Companies (BHC)

TIPRANKS
·
May 01

Evolus announces annual shareholder meeting via webcast

Reuters
·
Apr 29